NEW YORK – Quantabio is expanding its footprint in the newborn screening market with an agreement from a Wisconsin public health lab to adopt the company's dried blood spot (DBS) extraction and qPCR...
Read More
Wisconsin State Laboratory Adopts Quantabio Products to Improve Newborn Screening for Spinal Muscular Atrophy and Severe Combined Immunodeficiency
08.05.2019
Extracta DBS™ technology and PerfeCTa Multiplex qPCR ToughMix® kit used to develop and validate simultaneous screening method that can be quickly deployed in public health labs around the world
...
Read More
